Summary Seeking Alpha’s quant ratings system provides a valuable tool for analysis of thousands of stocks. Underlying metrics for momentum and revisions undercut Organogenesis’ strong Quant valuation and profitability metrics. Quant ratings alone need supplementation; the stories underlying particular stocks help to round out a decision of whether or not to invest. There are risks associated with healthcare microcaps in general and with Organogenesis specifically. txpeter/iStock via Getty Images This is my first look at Organogenesis (NASDAQ: ORGO ). It manufactures and sells surgical and sports medicine products to support the healing of musculoskeletal injuries and degenerative conditions. I have selected it as an interesting foil to use in evaluating Seeking Alpha’s rich quant ratings system ("Quant"). Initially I will explain how Quant works generally for healthcare stocks, then I will focus on its application in the case of Organogenesis. Lastly I will give an overview of Organogenesis’ substantive investment merits. Quant provides a dynamic tool crunching important metrics How it works Serious investors with time to spare who have not already done so can spend some interesting and instructive time learning Quant’s ins and outs. It is a tool rich with data. My particular field of interest is […]
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
